Framing the Chemical Advance (jacs-results-framing)

When to trigger

• You have results but the abstract/intro does not land a clear "advance"
• Reviewers (or co-authors) ask "what is genuinely new here?"
• The story reads as a list of experiments rather than one argument
• The significance is asserted ("important", "novel") rather than demonstrated

The advance, stated as a claim chain

A JACS narrative is a chain where each link is backed by data:

1. Problem — the chemical question or limitation, framed for broad interest.
2. Advance — the new reaction / structure / material / method / mechanism that addresses it.
3. Evidence — the specific data that prove the advance (yields/ee, spectra, X-ray, kinetics).
4. Generality / mechanism — why it is not a one-off (scope table; mechanistic basis).
5. Significance — what becomes possible now that did not before, across chemistry.

If any link rests on assertion rather than data, route to jacs-methods.

Framing the "broad interest"

Pick the dominant breadth driver and make the intro about it:

Title and abstract discipline

• Title states the chemistry, not the activity ("Catalytic Asymmetric X via Y", not "Studies toward X"). Avoid vague boosters.
• Abstract = problem → advance → key quantitative evidence → significance, in a few sentences. Put at least one hard number (yield, ee, TON, rate, λ, R-factor).
• The TOC/abstract graphic must visually encode the central advance, not decorate.

Calibrating novelty claims

• Compare against the closest prior art explicitly; state the delta in one line.
• Use "first" only if you have searched and can defend it; prefer "we show that".
• Match the strength of the claim to the strength of the data (controls, scope, mechanism).

Checklist

• One sentence names the advance and its breadth driver
• Each link in the claim chain points to specific evidence
• The closest prior art is cited and the delta stated
• Abstract contains at least one hard quantitative result
• TOC graphic encodes the central advance
• No significance claim exceeds what the data show

Anti-patterns

• "Novel" as a substitute for stating what is new
• Burying the advance under methodological detail in the intro
• Over-claiming generality from a narrow, hand-picked substrate set
• Significance framed as field hype rather than concrete new capability

Operating pass for Journal of the American Chemical Society

Treat this skill as an executable review pass, not a prose hint. First lock the chemical novelty, characterization chain, controls, and scope or mechanism evidence; then judge whether the current manuscript answers the venue's real reader: chemistry reviewers who expect a molecule/material/reaction claim to be supported by rigorous characterization and mechanistic insight.

• Do the pass: Return a claim-evidence-risk ledger rather than a prose-only diagnosis; every recommendation must point to a manuscript location or missing artifact.
• Return a ledger: give claim / evidence / risk / manuscript location rows, so the next agent can edit rather than rediscover the issue.
• Sibling guard: compare against ACS Central Science for broad conceptual reach, Angewandte for communication style, specialized ACS journals for narrower chemistry; if a sibling owns the contribution, recommend re-routing before polishing format.
• Stop condition: do not give submission-ready advice until the pack's resources/official-source-map.md has been checked for volatile rules and the manuscript has one concrete fix for the largest venue-specific risk.

Output format

【Advance】one-sentence claim
【Breadth driver】generality / concept / utility / selectivity
【Evidence map】advance → [data that proves it]
【Prior-art delta】vs <ref>: <one line>
【Gaps to close】route to jacs-methods if any link is unsupported
【Next】jacs-methods → jacs-figures

Related resources

• ../../resources/external_tools.md — what evidence each technique provides